PVI
CBIO

Pine Valley Investments’s Crescent Biopharma CBIO Stock Holding History

Pine Valley Investments’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-125
Closed -$2.63K – 580
2025
Q1 		$2.63K Hold
125
– – ﹤0.01% 559
2024
Q4 		$3.12K Hold
125
– – ﹤0.01% 517
2024
Q3 		$2.12K Buy
+125
New +$2.62K ﹤0.01% 516
2024
Q2 		– Sell
-125
Closed -$37.6K – 504
2024
Q1 		$37.6K Hold
125
– – ﹤0.01% 478
2023
Q4 		$29.5K Hold
125
– – ﹤0.01% 484
2023
Q3 		$18.8K Hold
125
– – ﹤0.01% 462
2023
Q2 		$21.8K Hold
125
– – ﹤0.01% 418
2023
Q1 		$19K Buy
+125
New +$28.1K ﹤0.01% 303

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return